Cognition Therapeutics

Cognition Therapeutics focuses on the discovery and development of small molecule therapies targeting toxic proteins that cause cognitive decline associated with Alzheimer's disease and other neurodegenerative diseases of the human brain. Toxic proteins play a crucial role in many disease targets, and there are currently no effective treatments to prevent the accumulation of toxic proteins or block their destructive effects. Cognition is built on the combination of unique biological expertise surrounding these targets, including proprietary assays emphasizing functional responses and proprietary medicinal chemistry ensuring new, high-quality small molecule drug candidates.